Curriculum Vitae s91

Curriculum Vitae Mary Anne Johnson, Ph.D., FOSA, FARVO Associate Professor

April, 2017

Personal Information Office: University of Maryland School of Medicine Department of Ophthalmology and Visual Science 10 S. Pine St., Room 500A Baltimore, MD 21201 Phone: (410) 706-1780 FAX: (410) 706-7057 e-mail: [email protected]

Education B.A. (Biology and Psychology) The University of Delaware, 1977 M.A. (Psychology) The Johns Hopkins University, 1980 Ph.D. (Psychology) The Johns Hopkins University, 1982

Post Graduate Education Postdoctoral Fellow (Ophthalmology), The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine (May, 1982 - July, 1983).

Employment History Assistant Professor, The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine (July, 1983 - May, 1989). Director, Clinical Visual Function Testing Laboratory, The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine (July, 1983 - July, 1993). Associate Professor, The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine (June, 1989 - July, 1993). Consultant (July 1993 - 1995): The Johns Hopkins Applied Physics Lab, The Naval Aerospace Medical Research Laboratory, Pensacola, FL; The Johns Hopkins University School of Medicine; Columbia University. Clinical Associate Professor, Department of Ophthalmology, University of Maryland School of Medicine (June 1, 1994 - 1998). Director, Visual Electrophysiology, Department of Ophthalmology, University of Maryland School of Medicine (June 1, 1994 - current). Associate Professor, Department of Ophthalmology, University of Maryland School of Medicine (1998 – current; tenured 2002).

Consultant Bayer Biogen Idec Cephalon Columbia University Eisai Medical Research, Inc. The Greater Baltimore Medical Center LKC Systems, Inc. Merck Oak Ridge Institute for Science and Education Ovation Pharmaceuticals The Johns Hopkins University Applied Physics Laboratory The National Geographic Society The National Institutes of Health The Naval Aerospace Medical Research Laboratories in Pensacola, FL, and San Antonio, TX The Veterans Administration Virginia Commonwealth University

Professional Memberships Association for Research in Vision and Ophthalmology Optical Society of America International Society for Clinical Electrophysiology of Vision

Honors Distinction in Psychology (University of Delaware, 1977) Fellow, Optical Society of America, 1993 Research to Prevent Blindness Disney Award (2003) Fellow, Association for Research in Vision and Ophthalmology (2010)

Administrative Service Institutional Service: University: Departmental liaison, Maryland Charity Campaign, 1996, 1997, 2005- 2009 Member, Dept. of Medicine Faculty Assembly, 2003-2007 Member, Communications Advisory Panel

Department: Chair, Search Committee for retinal surgeon, 1995 Member, Space Committee 1996, 1997 Member, Strategic Planning Committee 1997 Member, Computer Network Committee 1996-1999 Chair, Organizational Development Committee 1995-2002 Member, Research Committee 1996-2002 Member, Business and Development Committee 1998-2000 Chair, Expense Task Force 2000-2001 Member, Development Committee for the “Eye Disease Center for Health Disparities” Member, Resident Selection Committee, 1995 - present Member, Department Appointments, Promotions and Tenure Committee, 2014 – present Member, Oculoplastics Search Committee, 2014 Member, Neuro-ophthalmology Search Committee, 2014 Member, Resident Research Committee, 2014 – present

National Service: National Institutes of Health: Member, National Eye Institute Special Evaluation Panel, NIH, 1992-1994. Ad Hoc member, VisC Study Section, NIH, 10/96 Ad Hoc member, VisC Study Section, NIH, 10/01

Fight For Sight: Member, Study Section, 2005- 2007 2 Discover Magazine: Judge, Discover Magazine 1999 Award for Technological Innovation. Judge, Discover Magazine 2000 Award for Technological Innovation.

Lobbyist (unpaid), Eye Research Day on Capital Hill 9/6/2000

International Service:

 International Society for the Clinical Electrophysiology of Vision:

Member, Board of Directors, 2014-2017 Member, ISCEV organizing committee for the 2014 ISCEV annual meeting in Boston, MA. Convenor, Dodt Award 2014 Convenor, Marmor Award 2015-present Organizer, SIG on Animal Electrophysiology Member, Technical Program Committee 2014-present

 The Optical Society of America:

Advisory Positions: Member, Advisory Committee, Topical Meeting on Noninvasive Assessment of the Visual System, (1986 - 1990). Vice-Chair, Medical Optics Technical Group, The Optical Society of America, 1986 & 1987. Chair, Medical Optics Technical Group, The Optical Society of America, 1988, 1989 & 1990. Member, Technical Program Committee for the 1986, 1987, 1988, 1989 & 1990 Annual Meetings of the Optical Society of America. Member, Nominating Committee (For the President and Board of Directors), The Optical Society of America, 1988. Member, Technical Council of the Optical Society of America, 1988 - 1990. Director-at-Large, Board of Directors of the Optical Society of America, 1991-1993. Member, Finance Committee of the Optical Society of America, 1991-1992. Chair, OSA Ad Hoc Committee on Public Policy, 1992. Member, International Affairs Committee of the Optical Society of America, 1993. Member, Search Committee for the Optical Society of America Executive Director (1992-1993). Chair, Nominating Committee (For the President and Board of Directors), The Optical Society of America, 1995. Member, Executive Committee of the Technical Council of the Opt. Soc. of Am., 1996 - 1998. Member, Ad Hoc committee on Biomedical Optics, Optical Society of America, 1996-1999. Member, Committee on Biomedical Optics, Optical Society of America, 1999-present. Member, Optical Society of America Annual Meeting Rapid Action Committee, 1998-1999. Member, Nominating Committee (For the President and Board of Directors), The Optical Society of America, 1999. Member, OSA Nominating Committee for 2002 Annual Meeting Chairs (2000). Member, Rapid Action Committee on Topical Meetings, The Optical Society of America, 2001, 2002. Member, Teller Committee, The Optical Society of America, 2002. Chair, Teller Committee, The Optical Society of America, 2003. Past Chair, Teller Committee, The Optical Society of America, 2004. Member, Long Range Planning Committee (Publications), The Optical Society of America, 2006-2008.

Award Committees: Member, Frederic Ives Medal Committee of the Optical Society of America, 1993. Chair, Frederic Ives Medal Committee of the Optical Society of America, 1994. 3 Past-Chair, Frederic Ives Medal Committee of the Optical Society of America, 1995. Member, Archie Mahan Award Committee, OSA, 1997. Member, Alfred Lomb Medal Committee of the Optical Society of America, 2001 & 2002. Member, New Focus Student Award Committee, OSA, 2003 & 2004. Member, Esther Hoffman Beller Medal Committee, OSA, 2011-2012 (Chair, 2012). Member, Fellows Committee, Optical Society of America, 2012-2013

Meeting Organizer: Chair (with Dr. Thomas Baer), 1997 Annual Meeting of the Optical Society of America in Long Beach, CA. General Chair, Second Topical Meeting on Noninvasive Assessment of the Visual System, sponsored by the Optical Society of America (1986). Program Chair and co-originator, First Topical Meeting on Noninvasive Assessment of Visual Function, sponsored by the Optical Society of America (1985).

 The Association for Research in Vision and Ophthalmology (ARVO) Session moderator: 2014 and 2017 annual meetings

Editorial Positions: Applied Optics, the 1987 feature issue on "Noninvasive Assessment of the Visual System" (with Dr. Ray Applegate). Applied Optics, the 1988 feature issue on "Noninvasive Assessment of the Visual System" (with Drs. Ray Applegate and Steve Burns). Applied Optics, the 1989 feature issue on "Noninvasive Assessment of the Visual System" (with Drs. Ray Applegate and Steve Burns). Applied Optics, the 1991 feature issue on "Noninvasive Assessment of the Visual System" (with Drs. Ray Applegate and Steve Burns). Applied Optics, the 1992 feature issue on "Noninvasive Assessment of the Visual System" (with Drs. Ray Applegate and Steve Burns). Journal of the Optical Society of America A, the July and August, 1993 feature issues on "Noninvasive Assessment of the Visual System" (with Drs. Ray Applegate and Steve Burns). Applied Optics Optical Technology Editorial Advisory Board, 1990 - 1996. Optics & Photonics News Editorial Advisory Committee, 1994-1996. Investigative Ophthalmology and Visual Science Editorial Board, Guest Member, 2000-2001. Documenta Ophthalmologica , Editorial Board Member, 2012-present

Referee: Acta Ophthalmologica Scandinavica American Journal of Ophthalmology Annals of Neurology Applied Optics Archives of Ophthalmology Clinical Vision Sciences Current Eye Research Diabetologia Documenta Ophthalmologica European Journal of Ophthalmology European Journal of Pharmaceutics and Biopharmaceutics Experimental Eye Research Investigative Ophthalmology and Visual Science JAMA Ophthalmology Journal of Electroencephalography and Clinical Neurophysiology Journal of Ophthalmology Journal of the Optical Society of America A 4 Molecular Vision Ophthalmology Optometry and Visual Science PLoS One Retina Vision Neuroscience Vision Research

National Courses and Workshops: Instructor, "Practical Electrodiagnostics for the Clinician", The Wills Eye Hospital, March 16-17, 1983. Instructor of the workshop, "The ERG in Retinal Ischemia", presented September 14, 1985 and February 15, 1986, at the Wilmer Institute. Director, "Practical Ophthalmic Electrophysiology", an ongoing continuing education course for electrophysiology technicians (1986 - 1989). Director, clinical ERG conference: "The ERG in Retinal Vascular Disease", presented with Dr. George Bresnick on November 12, 1986, at the 1986 Annual Meeting of the American Academy of Ophthalmology in New Orleans, Louisiana. Instructor (with Dr. George Bresnick) of the course,"The Electroretinogram in Managing Ischemic Retinopathies", presented on November 12, 1987, at the 1987 Annual Meeting of the American Academy of Ophthalmology in Dallas, Texas. Instructor (with Dr. Robert Massof) of the course, "The Electroretinogram in Managing Diabetic Retinopathy", presented on December 3, 1987 at the 1987 Annual Meeting of the American Academy of Optometry in Denver, Colorado. Instructor (with Dr. Robert Massof) of the workshop, "Office Electroretinography", presented on December 4, 1987 at the 1987 Annual Meeting of the American Academy of Optometry in Denver, Colorado. Instructor (with Dr. George Bresnick) of the course,"The Electroretinogram in Managing Ischemic Retinopathies", presented on October 10, 1988, at the 1988 Annual Meeting of the American Academy of Ophthalmology in Las Vegas, Nevada. Director, clinical ERG conference: "The ERG in Retinal Vascular Disease", presented with Dr. George Bresnick on October 11, 1988, at the 1988 Annual Meeting of the American Academy of Ophthalmology in Las Vegas, Nevada. Director, clinical ERG conference: "The ERG in Retinal Vascular Disease", presented with Dr. George Bresnick on November 1, 1989, at the 1989 Annual Meeting of the American Academy of Ophthalmology in New Orleans, LA. Director (with Drs. Allan Rutzen and Scott Steidl) of the continuing education course: “Advances of Laser Applications in Ophthalmology”. Presented October 12, 1997, Long Beach, CA, at the Annual Meeting of the Optical Society of America. Director (with Drs. Allan Rutzen and Scott Steidl) of the continuing education course: “Advances of Laser Applications in Ophthalmology”. Presented at the 1998 Annual Meeting of the Optical Society of America in Baltimore, MD. Instructor, “Electrophysiology as an End Point in Animal Models”, The Wilmer Eye Institute, September 14, 2007. Instructor, “How electrophysiology can help you manage your patients”, presented as part of an optometry continuing education course given by the U. of MD Department of Ophthalmology and Visual Sciences, June 8, 2008. Instructor, “Electrophysiology as an End Point in Animal Models”, The Department of Ophthalmology, Texas Tech University Health Sciences Center, March 3-5, 2010. Instructor, “Human Electrophysiology Lab Practical”, The Department of Ophthalmology, Texas Tech University Health Sciences Center, March 3-5, 2010.

Case Presentations “Retina vs. optic nerve: Where is the source of this abnormality? Presented at the 2004 annual meeting of the International Society for Clinical Electrophysiology of Vision”, November 11, 2004, Puerto Rico. “How many rare disorders are you willing to diagnose in one patient?” Presented at the 2010 annual 5 meeting of the International Society for Clinical Electrophysiology of Vision”, November, 2010, Fremantle, Australia. “Is this Stargardt’s Disease? Or Best’s disease? Or Bestrophinopathy? Presented at the 2010 annual meeting of the International Society for Clinical Electrophysiology of Vision”, November, 2010, Fremantle, Australia. “Autoimmune Multisystem Neuropathy: When good cells go bad.” Presented at the 2011 annual meeting of the International Society for Clinical Electrophysiology of Vision”, September, 2011, Quebec City, Quebec, CA. “The case of the missing b-wave” Presented at the 2012 annual meeting of the International Society for Clinical Electrophysiology of Vision”, June, 2012, Valencia, Spain. “A case of amblyopia albinism cone dystrophy.” Presented at the 2015 annual meeting of the International Society for Clinical Electrophysiology of Vision”, June, 2015, Ljubljana, Slovenia.

Teaching Service (Institutional) Instructor, "Psychopharmacology", a course given in the Department of Psychology of the Johns Hopkins University, 1980. Instructor, the Johns Hopkins Medical Students' Lecture Series in Ophthalmology, 1986 – 1993. Instructor, the lecture series of the Ophthalmology Department of the Greater Baltimore Medical Center, 1987 – 1994. Instructor, The Wilmer Residents' Lecture Series, 1983 – 1993. Instructor, the lecture series of the Ophthalmology Department, University of Maryland School of Medicine, 1994 – present.

Mentor: 1) Postdoctoral fellows : Thomas McPhee, M.D., 1987-1988; Sergiu Marcus, M.D., 1987-1988; Patricia Quinlan, M.D., 1988-1989. 2) Residents: Michael Magbalon, M.D., 1999; Gagan Singh, M.D. 2000. 3) Medical students: David Choy, 1987; Julian Procope, 1991; Kendall Herschler, 1999; Michael Yao, 2001, Kevin Wang, 2003, Kathleen Oktavec, 2010

Member, Graduate Medical Education Review (1995, 1997-2002) Director (with Dr. Steven Bernstein) of Medical Student Education, Department of Ophthalmology (2001) Instructor, Neurophysiology, University of Maryland School of Medicine (2002).

Grant Support 1984 - 1994. NIH (RO1 EY-05118) "Studies of Visual Function in Retinal Ischemia", principal investigator (80%). 1984 - 1990. NIH (RO1 EY-05675) "Retinal Changes Accompanying Age-Related Drusen", co- investigator (20%, 1984-1987; 10% 1987-1990). 1988 - 1991. NIH (EY-82105) "ERG Ancillary Study to the Eye Disorders Case Control Study", principal investigator (5%). 1988 - 1991. NIH (2 R44 EY-07181) "Retinal Ischemia Monitor", co-investigator (5%). 1988 - 1994. NIH (UO1 EY-06750) "ERG Ancillary Study to the Central Vein Occlusion Study", Wilmer principal investigator and co-director (no percentage effort). 1991 - 1994. Through the JHU Applied Physics Laboratory "Effects of microwave radiation on the retina", co-investigator (20%). 1996 - 1997. Through a triservice award, Brooks Air Force Base, San Antonio, TX “Ocular effects in monkeys of high peaked power pulsed microwaves”, consultant (25%). 1997 - 2000. Hoesch Marion Rousell. Vigabatrin safety study. 1999 - 2000. Abbott Laboratories. Tiagabine safety study. 2000 - 2003. The Juvenile Diabetes Foundation International. “Macular Edema and Chorioretinopathy in Diabetes”, principal investigator (40%) ADC: $136,208, TDC: $408,898. 6 2003 - 2004. The Centers For Disease Control. “Visual Toxicity from Presumed Exposure to Pfiesteria”, principal investigator (30%) ADC: $94,725, TDC: $94,725. 2001 - 2004. NIH (EY-12658) "Chronic Ingestion of Lutein and Zeaxanthin in Primates", co- investigator (15%) ADC (for my lab only): $112,083, TDC: $232,101. 2003 - 2005 The Walt and Lily Disney Award for amblyopia research. TDC: $75,000. 2005 – 2009 Boehringer Ingelheim. Mirapex Safety Study. TDC: $27,000 2005 – 2008 Eisai. Safety study of E2007-206. Clinical center TDC: $26,976. Data Monitoring TDC: $10,000 est. 2007 - 2010 NIH (1R34MH073797) Light Treatment for Winter-SAD: Prediction of Response by Immediate Improvement. Consultant ($1800.00/yr). 2008 – 2013 NIH/NEI Mechanisms of Optic Nerve Stroke Protection, co-investigator (20%). ADC: $250,000, TDC: $1,250,000 2009 – 2014 NIH/NEI (1RO1 EY019529) Preclinical analysis of ischemic optic nerve treatment. Co-investigator (20%) ADC: $350,000, TDC: $1,750,000 2009 – 2010 NIH/NCMHHD (1R43MD003432-01A1) Screening Device for Diabetic Retinopathy. Co-Investigator (25%) TDC: $20,000 (and new electrophysiology system). 2012 Novartis. Efficacy of the 11C7 mAB in maintaining axons in a rat anterior optic neuropathy model. $110,000 TDC. (1/1/12-12/31/12) M. Johnson, P.I. (20%) 2014 – 2019 NIH/NEI Mechanisms of Optic Nerve Stroke Protection, co-investigator (20%). ADC: $250,000, TDC: $1,250,000

Publications Peer-Reviewed Journals: 1. Stark, W.S., Frayer, K.L., Johnson, M.A.: Photopigment and receptor properties in Drosophila compound eye and ocellar receptors. Biophy. Struct. Mechanism 5, 197-209 (1979). 2. Stark, W.S., Johnson, M.A.: Microspectrophotometry of Drosophila visual pigments: Determination of conversion efficiency in R1-6 receptors. J. comp. Physiol. 140, 275-286 (1980). 3. Massof, R.W., Johnson, M.A.: Prereceptor light absorption in setters with neuronal ceroid lipofuscinosis. Invest. Ophthalmol. Vis. Sci. 20, 134-136 (1981). 4. Massof, R.W., Johnson, M.A., Finkelstein, D.: Peripheral absolute threshold spectral sensitivity in retinitis pigmentosa. Brit. J. Ophthalmol. 65, 112-121 (1981). 5. Johnson, M.A., Massof, R.W.: The effect of stimulus size on chromatic thresholds in the peripheral retina. In: Color Vision Deficiencies VI, G. Verriest (ed.), Vol. 33, The Hague: Dr. W. Junk Publishers, pp. 15-18 (1982). 6. Johnson, M.A., Frayer, K.L., Stark, W.S.: Characteristics of rdgA : Mutants with retinal degeneration in Drosophila. J. Insect Physiol. 28, 233-242 (1982). 7. Johnson, M.A., Massof, R.W.: The photomyoclonic reflex: An artifact in the clinical electroretinogram. Brit. J. Ophthalmol. 66, 368-378 (1982). 8. Stark, W.S., Chen, D-M., Johnson, M.A., Frayer, K.L.: The rdgB gene in Drosophila : I. Retinal degeneration in different mutant alleles and inhibition of degeneration by norpA. J. Insect Physiol. 29, 123- 131 (1983). 9. Massof, R.W., Wu, L., Finkelstein, D., Perry, C., Starr, S.J., Johnson, M.A.: Properties of electroretinographic intensity-response functions in retinitis pigmentosa. Doc. Ophthalmol. 57, 279-296 (1984). 10. Sunness, J.S., Massof, R.W., Johnson, M.A., Finkelstein, D., Fine, S.L.: Peripheral retinal function in age-related macular degeneration. Arch. Ophthalmol. 103, 811-816 (1985). 11. DeBustros, S., Glaser, B.M., Johnson, M.A.: Thrombin infusion for the control of intraocular bleeding during vitreous surgery. Arch. Ophthalmol. 103, 837-839 (1985). 12. Johnson, M.A.: Color vision in the peripheral retina. Am. J. Opt. Physiol. Opt. 63, 97-103 (1986). 13. Massof, R.W., Johnson, M.A., Sunness, J.S., Perry, C., Finkelstein, D.: Flicker electroretinogram in retinitis pigmentosa. Doc. Ophthalmol. 62, 231-245 (1986). 14. Jabs, D.A., Miller, N.R., Newman, S.A., Johnson, M.A., Stevens, M.B.: Optic neuropathy in systemic lupus erythematosus. Arch. Ophthalmol. 104, 564-568 (1986). 15. Johnson, M.A., Choy, D.: On the definition of age-related norms for visual function testing. Appl. 7 Optics 26, 1449-1454 (1987). 16. Sunness, J.S., Johnson, M.A., Massof, R.W., Kays, D.L.: The Wilmer fundus camera stimulator. Appl. Optics 26, 1487-1491 (1987). 17. Johnson, M.A., Marcus, S., Elman, M.J., McPhee, T.J.: Neovascularization in central retinal vein occlusion: Electroretinographic findings. Arch. Ophthalmol. 106, 348-352 (1988). 18. Sunness, J.S., Johnson, M.A., Massof, R.W., Marcus, S.: Retinal sensitivity over drusen and non- drusen areas: A study using fundus perimetry. Arch. Ophthalmol. 106, 1081-1084 (1988). 19. Massof, R.W., Choy, D., Sunness, J.S., Johnson, M.A., Rubin, G.S., Fine, S.L.: Foveal threshold elevations associated with age-related drusen. Clin. Vis. Sci. 4, 221-227 (1989). 20. Johnson, M.A., Drum, B.A., Quigley, H.A., Sanchez, R.M., Dunkelberger, G.R.: Pattern-evoked potentials and optic nerve fiber loss in monocular laser-induced glaucoma. Invest. Ophthalmol. Vis. Sci. 30, 897-907 (1989). 21. Sunness, J.S., Massof, R.W., Johnson, M.A., Bressler, N.M., Bressler, S.B., Fine, S.L.: Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration. Ophthalmol. 96, 375-381 (1989). 22. Severns, M.L., Johnson, M.A., Merritt, S.A.: Automated estimation of latency and amplitude from the flicker electroretinogram. Appl. Optics 30, 2106 - 2112 (1991). 23. Madreperla, S.A., Johnson, M.A., O'Brien, T. P.: Corneal endothelial dysfunction in digoxin toxicity. Amer. J. Ophthalmol. 113:211-212 (1992). 24. Johnson, M.A., McPhee, T.J.: Electroretinographic findings in iris neovascularization due to acute central retinal vein occlusion. Arch. Ophthalmol. 111: 806-814 (1993). 25. Lim, J. I., Fine, S.L., Kues, H.A., Johnson, M.A.: Visual abnormalities associated with high energy microwave exposure. Retina 13: 230-233 (1993). 26. Severns, M.L., Johnson, M.A.: Predicting outcome in central retinal vein occlusion using the flicker electroretinogram. Arch. Ophthalmol. 111: 1123-1130 (1993). 27. Severns, M.L., Johnson, M.A.: Variability of the b-wave of the human ERG with intensity. Doc. Ophthalmol. 84: 291-299 (1993). 28. Severns, M.L., Johnson, M.A.: The care and fitting of Naka-Rushton functions to electroretinographic intensity-response data. Doc. Ophthalmol. 85: 135-150 (1993). 29. Madreperla, S.A., Johnson, M.A., Nakatani, K.: Electrophysiologic and electroretinographic evidence for photoreceptor dysfunction as a toxic effect of digoxin. Arch. Ophthalmol. 112: 807-812 (1994). 30. Severns, M.L., Johnson, M.A., Bresnick, G.H.: Methodological dependence of electroretinogram oscillatory potential amplitudes. Doc. Ophthalmol. 86: 23-31 (1994). 31. Johnson, M.A., Hood, D.C.: Rod photoreceptor transduction is affected in central retinal vein occlusion associated with iris neovascularization. J. Opt. Soc. Am. A. 13: 572-576 (1996). 32. Krauss, G.L., Johnson, M.A., Miller, N.R.: Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology 50: 1-5 (1998). 33. Miller, N.R., Johnson, M.A., Paul, S.R., Girkin, C.A., Perry, J.D., Medura, M., Krauss, G.L.: Visual dysfunction in patients receiving vigabatrin for intractable seizures: Clinical and electrophysiologic findings. Neurology 53: 2082-2087 (1999). 34. Lu, S-T, Mathur, S.P., Stuck, B., Zwick, H., D'Andrea, J.A., Ziriax, J.M., Merritt, J.H., Lutty, G.A., McLeod, D.S., Johnson, M.A.: Effects of high peak power microwaves on the retina of the rhesus monkey. Bioelectromagnetics 21: 439-454 (2000). 35. Johnson, M.A., Krauss, G.L., Miller, N.R., Medura, M., Paul, S.R.: Visual function loss from vigabatrin: Effect of stopping the drug. Neurology 55: 40-45 (2000). 36. Nguyen, A., Johnson, M.A., Hutcheson, K.A.: Good visual function in posterior microphthalmos. J. Amer. Assoc. Ped. Ophthalmol. Strabismus 4: 240-242 (2000). 37. Paul, S.R., Krauss, G.L., Miller, N.R., Medura, M., Dollar, L., Johnson, M.A.: Visual function is stable in patients who continue chronic vigabatrin therapy: Implications for clinical decision making. Epilepsia 4: 525-530 (2001). 38. Krauss, G.L., Johnson, M.A., Sheth, S., Miller, N.R.: A controlled study comparing visual function in patients treated with vigabatrin and tiagabine. J. Neurol. Neurosurg. Psychiatry 74: 339-343 (2003). 39. Bernstein, S.L., Guo, Y, Kelman, SE, Flower, RW, Johnson, MA: Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 44: 4153-4162 (2003). 8 40. Kim, S.Y., Johnson, M.A., McLeod, D.S., Alexander, T., Otsuji, T., Steidl, S.M., Hansen, B.C., Lutty, G.A.: Retinopathy in monkeys with spontaneous type 2 diabetes. Invest. Ophthalmol. Vis. Sci. 45:4543 – 4553 (2004). 41. Johnson, M.A., , Lutty, G.A., McLeod, D.S., Otsuji, T., Flower, R.W., Sandagar, G., Alexander, T., Steidl, S.M., Hansen, B.C.: Ocular structure and function in a monkey with spontaneous diabetes mellitus. Exp Eye Res 80:37-42 (2005). 42. Kim, SY, Johnson, MA, McLeod, DS, Alexander, T, Hansen, BC, Lutty, GA: Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes 54(5):1534-42 (2005). 43. Khachik F, London E, de Moura FF, Johnson M, Steidl S, Detolla L, Shipley S, Sanchez R, Chen XQ, Flaws J, Lutty G, McLeod S, Fowler B: Chronic ingestion of (3R,3'R,6'R)-lutein and (3R,3'R)-zeaxanthin in the female rhesus macaque. Invest Ophthalmol Vis Sci. 47(12):5476-86 (2006). 44. Chen, CS*, Johnson, MA*, Flower, RA, Slater, BJ, Miller, NR, Bernstein, SL: A primate model of non-arteritic anterior ischemic optic neuropathy (pNAION). Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2985- 92. * First authors contributed equally 45. Johnson, MA, Slater, BJ, Miller, NR, Bernstein, SL, Flower, RA: A simple integrated system for electrophysiologic recordings in animals. Doc Ophthalmol. 2009 119:9-12. Epub 2009 Jan 10. 46. Nichols LL 2nd, Alur RP, Boobalan E, Sergeev YV, Caruso RC, Stone EM, Swaroop A, Johnson MA, Brooks BP: Two novel CRX mutant proteins causing autosomal dominant Leber congenital amaurosis interact differently with NRL. Hum Mutat. 2010 Jun;31(6):E1472-83. 47. Bernstein SL, Johnson MA, Miller NR.: Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Prog Retin Eye Res. 2011 May; 30(3): 167-187. 48. Sayegh RR, Madsen KA, Adler JD, Johnson MA, Mathews MK: Diffuse retinal injury from a non- penetrating TASER dart. Doc Ophthalmol. 123: 135-139 (2011). 49. Sleemi A, Johnson MA, Rohan KJ, Okusaga O, Adediran T, Uzoma H, Walsh C, Reeves G and Postolache TT: Reading increases ocular illuminance during light treatment- implications for managing seasonal affective disorder. Int J Adolesc Med Health 2012;24(4): 339-42. 50. Reeves GM, Nijjar GV, Langenberg P, Johnson MA, Khabazghazvini B, Sleemi A, Vaswani D, Lapidus M, Manalai P, Tariq M, Acharya M, Cabassa J, Snitker S, Postolache TT: Improvement in depression scores after 1 hour of light therapy treatment in patients with seasonal affective disorder. J Nerv Ment Dis 2012; 200(1): 51-5. 51. Bach M, Brigell MG, Hawlina M, Holder GE, Johnson MA, McCulloch DL, Meigen T, Viswanathan S. ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc Ophthalmol. 2012 Oct 17. [Epub ahead of print] Doc Ophthalmol. 2013 Feb;126(1):1-7. 52. Touitou V, Johnson MA, Guo Y, Miller NR, Bernstein SL: Sustained Neuroprotection From a Single Intravitreal Injection of PGJ2 in a Rodent Model of Anterior Ischemic Optic Neuropathy. Invest Ophthalmol Vis Sci. 2013 Nov 11;54(12):7402-9. 53. Miller NR, Johnson MA, Theresa T, Guo Y, Bernstein AM,Bernstein SL: Sustained Neuroprotection from a Single Intravitreal Injection of PGJ2 in a Non-Human Primate Model of Nonarteritic Anterior Ischemic Optic Neuropathy. Invest Ophthalmol Vis Sci. 2014 Nov 55 (11): 7047-7056. 54. Zhang L, Evans DS, Raheja UK, Stephens SH, Stiller JW, Reeves GM, Johnson M, Ryan KA, Weizel N, Vaswani D, McLain H, Shuldiner AR, Mitchell BD, Hsueh WC, Snitker S, Postolache TT: Chronotype and seasonality: Morningness is associated with lower seasonal mood and behavior changes in the Old Order Amish. J. Affective Disorders 2015 (174): 209-214. 55. Uzoma HN, Reeves GM, Langenberg P, Khabazghazvini B, Balis TG, Johnson MA, Sleemi A, Scrandis DA, Zimmerman SA, Vaswani D, Nijjar GV, Cabassa J, Lapidus M, Rohan KJ, Postolache TT: Light treatment for seasonal winter depression in African-American vs. Caucasian outpatients. World J Psychiatry 2015 Mar 22;5(1):138-46. doi: 10.5498/ Published online Nov. 2014. PMCID: PMC4369543 56. Miller NR, Johnson MA, Nolan T, Guo Y, Bernstein SL: A single intravitreal injection of ranibizumab provides no neuroprotection in a nonhuman primate model of moderate-to-severe nonarteritic anterior ischemic optic neuropathy. Invest. Ophthalmol Vis Sci 2015 56 (13): 7679-7686. 57. Margo JA, Schocket LS, Klima K, Johnson MA: Persistent retinal changes after intravitreal ocriplasmin. Retinal Cases & Brief Reports 2016 10 (1): 48-51. 58. Johnson MA, Miller NR, Nolan T, Bernstein SL: Peripapillary Retinal Nerve Fiber Layer Swelling Predicts Peripapillary Atrophy in a Primate Model of Nonarteritic Anterior Ischemic Optic Neuropathy. Invest Ophthalmol Vis Sci. 2016 Feb 1;57(2):527-32. 9 59. Guo Y, Johnson MA, Mehrabian Z, Mishra MK, Rangaramanujam K, Miller NR, Bernstein SL: Dendrimers target the ischemic lesion in rodent and primate models of nonarteritic anterior ischemic optic neuropathy. PLoS One 2016 Apr 29;11(4):e0154437. doi: 10.1371/journal.pone.0154437. PMCID: PMC4851377 60. Tzvetelina D. Dimitrova, MD, Gloria M. Reeves, MD, Manana Lapidus, MD, Aamar Sleemi, MD, Monika Acharya, MD, Theodora G. Balis, MD, Partam Manalai, MD, Muhammad Tariq, MD, Johanna Cabassa, MD, Mary A. Johnson, PhD, Patricia Langenberg, PhD, Kelly J. Rohan, Ph D, Michael Miller, MD, Teodor T. Postolache, MD: Prediction of Outcome with Bright Light Treatment in Patients with Seasonal Affective Disorder. J. Aff. Dis. (in press).

Chapters: 1. Johnson, M.A.: B/A-wave amplitude ratios in retinal vascular disease. In : Heckenlively, J. & Arden, G. (eds.): Principles and Practice of Clinical Electrophysiology of Vision. Mosby Year Book, Inc., St. Louis, 1991, (pp. 531-536). 2. Johnson, M.A.: Use of electroretinographic ratios in assessment of vascular occlusion and ischemia. In : Heckenlively, J. & Arden, G. (eds.): Principles and Practice of Clinical Electrophysiology of Vision. Mosby Year Book, Inc., St. Louis, 1991, (pp. 613-618). 3. Johnson, M.A.: Diseases of the Middle Retina: Venous and Arterial Occlusions. In : Heckenlively, J. & Arden, G. (eds.): Principles and Practice of Clinical Electrophysiology of Vision, 2nd edition. MIT Press, Cambridge, MA, 2006. (pp. 675 – 681).

Technical Digests: 1. Johnson, M.A., Miller, N.R.: Visual evoked potential tuning functions in optic neuritis and optic neuropathy. In: Noninvasive Assessment of the Visual System Technical Digest, 1985 (Optical Society of America, Washington, D.C., 1985), Vol. 85.6, pp. WB3-1. Presented in Lake Tahoe at the first OSA topical meeting on Noninvasive Assessment of Visual Function, March 19-20, 1985. 2. Johnson, M.A., Finkelstein, D.: The electroretinogram in ischemic retinopathies. In: Noninvasive Assessment of the Visual System Technical Digest, 1986 (Optical Society of America, Washington, D.C., 1986), Vol. 1, pp. MC3-1 to 4. Presented in Monterey at the second OSA topical meeting on Noninvasive Assessment of the Visual System, March 24-26, 1986. 3. Sunness, J.S., Johnson, M.A., Massof, R.W.: Visual function over drusen in age-related macular degeneration: Direct measurements using the fundus camera stimulator. In: Noninvasive Assessment of the Visual System Technical Digest, 1987 (Optical Society of America, Washington, D.C., 1987), Vol. 1, pp. 171- 173. Presented by M.A. Johnson at the 1987 OSA topical meeting on "Noninvasive Assessment of the Visual System". January 26-28, 1987. 4. Johnson, M.A., Hood, D.C.: A theoretical interpretation of ERG abnormalities in central retinal vein occlusion. In: Noninvasive Assessment of the Visual System Technical Digest, 1988 (Optical Society of America, Washington, D.C., 1988), Vol. 3, pp. 84-87. Presented at the 1988 OSA Topical Meeting on Noninvasive Assessment of the Visual System. 5. Johnson, M.A., Procope, J., Quinlan, P.M.: Electroretinographic oscillatory potentials and their role in predicting treatable complications in patients with central retinal vein occlusion. In: Noninvasive Assessment of the Visual System Technical Digest, 1990 (Optical Society of America, Washington, D.C., 1990), Vol. 3, pp. 62-65. Presented at the 1990 OSA Topical Meeting on Noninvasive Assessment of the Visual System, Feb. 5, 1990. 6. Severns, M.L., Johnson, M.A.: Automated implicit time and amplitude determination for the 30 Hz flicker electroretinogram: Performance in prediction of neovascularization in central retinal vein occlusion. In: Noninvasive Assessment of the Visual System Technical Digest, 1991 (Optical Society of America, Washington, D.C., 1991), Vol. 1, pp. 10 - 13. Presented by M. Severns at the 1991 OSA Topical Meeting on Noninvasive Assessment of the Visual System, Santa Fe, NM, Feb. 4, 1991. 7. Severns, M.L., Johnson, M.A., Khadjenouri, D.: Use of a Neural Network to Classify Electroretinograms in Central Retinal Vein Occlusion. In: Noninvasive Assessment of the Visual System Technical Digest, 1992 (Optical Society of America, Washington, D.C., 1992), Vol. 1, pp. 136 - 139. Presented by M. Severns at the 1992 OSA Topical Meeting on Noninvasive Assessment of the Visual System, 10 Santa Fe, NM, Jan. 28 , 1992. 8. Johnson, M.A., Hood, D.C.: Rod phototransduction is altered in proliferative central retinal vein occlusion. In: Vision Science and Its Applications. Vol. 1, 1995 OSA Technical Digest Series (Optical Society of America, Washington, D.C., 1995), pp. 264-267. Presented at the 1995 OSA Topical Meeting on Vision Science and Its Applications, Santa Fe, NM.

Presentations and Published Abstracts: 1. Johnson, M.A., Frayer, K.L., Stark, W.S.: Electrophysiologic and microspectrophotometric characterization of two Drosophila retinal degeneration mutants. Invest. Ophthalmol. Vis. Sci. Suppl., p.4 (1979). Presented at the April, 1979, annual meeting of the Association for Research in Vision and Ophthalmology. 2. Johnson, M.A., Massof, R.W.: The photochromatic interval in the peripheral retina. Recent Advances in Vision Technical Digest, p. FB3 (1980). Presented at the April, 1980, Vision Topical meeting of the Optical Society of America. 3. Johnson, M.A., Massof, R.W., and Finkelstein, D.: Peripheral absolute threshold spectral sensitivity in retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. Suppl., p. 213 (1980). Presented at the May, 1980, annual meeting of the Association for Research in Vision and Ophthalmology. 4. Johnson, M.A., Massof, R.W.: An artifact in the clinical electroretinogram. J. Opt. Soc. Am., p. 1616 (1980). Presented in Chicago at the October, 1980, annual meeting of the Optical Society of America. 5. Massof, R.W., Wu, L., Finkelstein, D., Perry, C., Starr, S.J., Fitzke, F.W., Johnson, M.A.: Properties of the electroretinogram in retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. Suppl., p. 121 (1981). Presented by R.W. Massof at the April, 1981, annual meeting of the Association for Research in Vision and Ophthalmology. 6. Johnson, M.A., Massof, R.W.: The photomyoclonic reflex: An artifact in the clinical electroretinogram. Invest. Ophthalmol. Vis. Sci. Suppl., p. 121 (1981). Presented at the April, 1981, annual meeting of the Association for Research in Vision and Ophthalmology. 7. Johnson, M.A., Massof, R.W.: The effect of stimulus size on chromatic thresholds in the peripheral retina. Presented by R.W. Massof at the September, 1981, annual meeting of the International Research Group on Color Vision Deficiencies. 8. Johnson, M.A., Massof, R.W.: Spatial properties of chromatic mechanisms in the peripheral retina. J. Opt. Soc. Am. 71, p. 1608 (1981). Presented in Orlando at the October, 1981, annual meeting of the Optical Society of America. 9. Johnson, M.A., Massof, R.W.: Changes in the spatial characteristics of chromatic mechanisms with eccentricity. Invest. Ophthalmol. Vis. Sci. Suppl. 22, p. 121 (1982). Presented at the April, 1982, annual meeting of the Association for Research in Vision and Ophthalmology. 10. Johnson, M.A., Massof, R.W.: Measurements of refractive error resulting from off-axis stimulation. J. Opt. Soc. Am. 72, p. 1814 (1982). Presented in Tucson at the October, 1982, annual meeting of the Optical Society of America. 11. Johnson, M.A., Finkelstein, D., Massof, R.W.: Retinal function in branch vein occlusion. Invest. Ophthalmol. Vis. Sci. Suppl. 24, p. 296 (1983). Presented at the May, 1983, annual meeting of the Association for Research in Vision and Ophthalmology. 12. Johnson, M.A., Massof, R.W.: Temporal resolution as a function of eccentricity and target size. J. Opt. Soc. Am. 73, p. 1872 (1983). Presented in New Orleans at the October, 1983, annual meeting of the Optical Society of America. 13. Johnson, M.A., Massof, R.W.: Evidence for temporal aliasing in the peripheral retina. Invest. Ophthalmol. Vis. Sci. Suppl. 25, p. 52 (1984). Presented at the May, 1984, annual meeting of the Association for Research in Vision and Ophthalmology. 14. DeBustros, S., Glaser, B.M., Johnson, M.A., DeJuan, E.: Thrombin infusion for the control of intraocular bleeding during vitreous surgery. Invest. Ophthalmol. Vis. Sci. Suppl. 25, p. 309 (1984). Presented by S. DeBustros at the May, 1984, annual meeting of the Association for Research in Vision and Ophthalmology. 15. Sunness, J.S., Massof, R.W., Johnson, M.A., Finkelstein, D., Fine, S.L.: Age-related macular degeneration and peripheral retinal function. Invest. Ophthalmol. Vis. Sci. Suppl. 26, p. 58 (1985). Presented by J. Sunness at the 1985 annual meeting of the Association for Research in Vision and Ophthalmology. 16. Walsh, P.M., Stark, W.J., Johnson, M.A., D'Anna, S.: Use of 5-fluorouracil to prevent posterior 11 capsule opacification. Invest. Ophthalmol. Vis. Sci. Suppl. 26, p. 191 (1985). Presented by P. Walsh at the 1985 annual meeting of the Association for Research in Vision and Ophthalmology. 17. Johnson, M.A., Finkelstein, D.: The electroretinogram in retinal vein occlusion. Invest. Ophthalmol. Vis. Sci. Suppl. 26, p. 323 (1985). Presented at the 1985 annual meeting of the Association for Research in Vision and Ophthalmology. 18. Johnson, M.A., Sunness, J.S., Massof, R.W., Kays, D.L.: Fundus camera stimulator. Presented in Washington, D.C., at the 1985 annual meeting of the Optical Society of America. 19. Drum, B.A., Johnson, M.A., Quigley, H.A., Sanchez, R., Dunkelberger, G.: Pattern ERG and optic nerve histology in monkeys with unilateral laser-induced glaucoma. Invest. Ophthalmol. Vis. Sci. Suppl. 27, p. 40 (1986). Presented by B. Drum at the 1986 annual meeting of the Association for Research in Vision and Ophthalmology. 20. Johnson, M.A., Finkelstein, D.: Neovascularization and retinal sensitivity loss in patients with retinal ischemia. Invest. Ophthalmol. Vis. Sci. Suppl. 27, p. 145 (1986). Presented at the 1986 annual meeting of the Association for Research in Vision and Ophthalmology. 21. Jabs, D.A., Miller, N.R., Johnson, M.A., Stevens, M.B.: Lupus optic neuropathy: Clinical presentations and electrophysiologic correlates. Presented by D. Jabs at the 1986 annual meeting of the American Rheumatism Association. 22. Johnson, M.A., Marcus, S., Elman, M.J.: ERG sensitivity loss in venous stasis retinopathy. Invest. Ophthalmol. Vis. Sci. Suppl. 28, p. 319 (1987). Presented at the 1987 annual meeting of the Association for Research in Vision and Ophthalmology. 23. Sunness, J.S., Johnson, M.A., Massof, R.W., Kays, D., Fine, S.L.: Fundus perimetry in patients with drusen and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. Suppl. 28, p. 7 (1987). Presented by J. Sunness at the 1987 annual meeting of the Association for Research in Vision and Ophthalmology. 24. McPhee, T.J., Johnson, M.A., Massof, R.W. and Finkelstein, D.: ERG after fundus photography and fluorescein angiography. Invest. Ophthal. Vis Sci. Suppl. 28, p. 236 (1987). Presented by T. McPhee at the 1987 annual meeting of the Association for Research in Vision and Ophthalmology. 25. McPhee, T.J., Johnson, M.A., Elman, M.J., Finkelstein, D.: Electroretinographic findings in iris neovascularization due to acute central retinal vein occlusion. Presented as a poster on Nov. 8-12, 1987, at the 1987 annual meeting of the American Academy of Ophthalmology in Dallas, Texas. 26. Johnson, M.A.: Defining age-related norms for visual function testing. Presented at the 1987 Annual Meeting of the Gerontological Society of America, as part of the symposium "Does Visual Function Decline with Age Independently of Visual Pathology?" 27. McPhee, T.J., Johnson, M.A., Elman, M.J.: Electroretinography findings in iris neovascularization due to acute central retinal vein occlusion. Invest. Ophthal. Vis Sci. Suppl. 29, p. 67 (1988). Presented by T. McPhee at the 1988 annual meeting of the Association for Research in Vision and Ophthalmology. 28. Quinlan, P.M., Johnson, M.A., Elman, M.J.: The relative afferent pupillary defect and ERG abnormalities in central retinal vein occlusion. Invest. Ophthal. Vis Sci. Suppl. 29, p. 67 (1988). Presented by P. Quinlan at the 1988 annual meeting of the Association for Research in Vision and Ophthalmology. 29. Johnson, M.A., Massof, R.W.: Photoreceptor sensitivity loss in patients with central retinal vein occlusion and iris neovascularization. Invest. Ophthal. Vis Sci. Suppl. 29, p. 179 (1988). Presented at the 1988 annual meeting of the Association for Research in Vision and Ophthalmology. 30. Johnson, M.A., McPhee, T.J.: The natural history of electroretinogram changes in central retinal vein occlusion. Invest. Ophthal. Vis Sci. Suppl. 30, p. 477 (1989). Presented at the 1989 annual meeting of the Association for Research in Vision and Ophthalmology. 31. Yeo, J.H., O'Brien, T. P., Green, W. R., Johnson, M.A., Greenberg, K.A., Gottsch, J.D.: Ciprofloxacin: Oral penetration into the eye & retinal toxicity of intravitreal injection. Invest. Ophthal. Vis Sci. Suppl. 30, p. 381 (1989). Presented by J. H. Yeo at the 1989 annual meeting of the Association for Research in Vision and Ophthalmology. 32. Quinlan, P.M., Johnson, M.A., Hiner, C.J., Elman, M.J.: Fluorescein Angiography and electroretinography as predictors of neovascularization in central retinal vein occlusion. Invest. Ophthal. Vis Sci. Suppl. 30, p. 392 (1989). Presented by P. M. Quinlan at the 1989 annual meeting of the Association for Research in Vision and Ophthalmology. 33. Johnson, M.A., Quinlan, P.M., McPhee, T.J.: Quantifying retinal ischemia with the electroretinogram. Presented at the Second International Symposium on Ocular Circulation and Neovascularization in Baltimore, September, 1989. 12 34. Johnson, M.A., Severns, M.L., Kelman, S.E.: Use of a neural network to analyze ERG parameters in central retinal vein occlusion. Invest. Ophthal. Vis. Sci. Suppl. 31, p. 568 (1990). Presented at the 1990 annual meeting of the Association for Research in Vision and Ophthalmology. 35. Johnson, M.A., Severns, M.L., Kelman, S.E.: Using a neural network and the electroretinogram to classify central retinal vein occlusion. Perception 19, 367 (1990). Presented at the 13th European Conference on Visual Perception, Paris, France, September 4-7, 1990. 36. Johnson, M.A., Procope, J., Severns, M.L.: Electroretinographic oscillatory potentials in central retinal vein occlusion. Invest. Ophthal. Vis Sci. Suppl. 32, p. 1227 (1991). Presented at the 1991 annual meeting of the Association for Research in Vision and Ophthalmology. 37. Kues, H., McLeod, D.S., D'Anna, S., Johnson, M.A., Perry, C.R., Monihan, J.C.: Microwave- induced electroretinographic changes in the primate. Presented by H. Kues at the 13th Annual Meeting of the Bioelectromagnetic Society, Salt Lake City, Utah, June 23-27, 1991. 38. Johnson, M.A., McLeod, D.S., Lutty, G.A., D'Anna, S.A., Perry, C.R., Kues, H.A.: Microwave- induced retinal damage in the primate. Invest. Ophthal. Vis Sci. Suppl. 33, p. 1310 (1992). Presented at the 1992 annual meeting of the Association for Research in Vision and Ophthalmology. 39. Johnson, M.A., Pasquale, L.R.: Foveal temporal contrast sensitivity in end-stage glaucoma. Invest. Ophthal. Vis Sci. Suppl. 34, p. 1267 (1993). Presented at the 1993 annual meeting of the Association for Research in Vision and Ophthalmology. 40. Madreperla, S.A., Johnson, M.A., Nakatani, K.: An explanation for the visual symptoms of digoxin toxicity based on clinical electroretinography and in vitro studies on isolated photoreceptors. Invest. Ophthal. Vis Sci. Suppl. 34, p. 1304 (1993). Presented by S. Madreperla at the 1993 annual meeting of the Association for Research in Vision and Ophthalmology. 41. Kues, H.A., D’Anna, S.A., Johnson, M.A., Green, W.R., Brooks, L.J., Monahan, J.C.: The importance of specific microwave parameters for the induction of ocular effects in the non-human primate. Presented by H. Kues at the 16th Annual Meeting of the Bioelectromagnetic Society, 1994. 42. Johnson, M.A., Hood, D.C.: Central retinal vein occlusion (CRVO) can affect transduction in rod photoreceptors. Invest. Ophthal. Vis Sci. Suppl. 35, p. 1374 (1994). Presented at the 1994 annual meeting of the Association for Research in Vision and Ophthalmology. 43. Johnson, M.A., Hood, D.C.: Rod sensitivity loss predicts neovascularization in central retinal vein occlusion. Invest. Ophthal. Vis Sci. Suppl. 36, p. S619 (1995). Presented at the 1995 annual meeting of the Association for Research in Vision and Ophthalmology. 44. Johnson, M.A., Shady, S., Wladis, T.E., Hood, D.C., Brigell, M.G.: Rod phototransduction abnormalities in central retinal vein occlusion with iris neovascularization. Invest. Ophthal. Vis Sci. Suppl. 37, p. S141 (1996). Presented at the 1996 annual meeting of the Association for Research in Vision and Ophthalmology. 45. Brigell, M. & the CVOS-ERG Study Group: The role of the baseline ERG in prediction of subsequent neovascular changes following central retinal vein occlusion. Presented by M. Brigell at the 1996 annual meeting of the International Society for Clinical Electrophysiology of Vision, July 20-24, 1996, Tubingen, Germany. 46. Johnson, M.A., Quo, P., Johnson, L., Howell, C.: Rod phototransduction abnormalities in vitamin A deficiency. Invest. Ophthal. Vis Sci. Suppl. 38, p. S316 (1997). Presented at the 1997 annual meeting of the Association for Research in Vision and Ophthalmology. 47. D’Andrea, J.A., Ziriax, J.M., Lu, S-T., Mathur, S., Merritt, J.H., Johnson, M., Lutty, G., Zwick, H., Stuck, B.: Rhesus monkey vision after exposure to high peak power microwave pulses. In: Abstracts of the Second World Congress for Electricity and Magnetism in Biology and Medicine, 1997. Presented by J. D’Andrea, June 8-13, 1997, Bologna, Italy. 48. Johnson, M. A. , Krauss, G. L. and Miller, N. R. : Vigabatrin-Associated Reductions in the Electroretinogram. IOVS Suppl. 39, p. S831, 1998. Presented at the 1998 annual meeting of the Association for Research in Vision and Ophthalmology. 49. Krauss, G.L., Johnson, M.A., Paul, S., Miller, N.R.: Electroretinogram (ERG) and ophthalmologic findings in patients treated with vigabatrin.” Presented at the 1998 annual meeting of the American Epilepsy Society. 50. Johnson, M.A., Sandagar, G., Steidl, S.M., Woel, V., Herschler, K.: Ophthalmic, central retinal and posterior ciliary arterial disease in asymmetric diabetic retinopathy. Invest. Ophthal. Vis Sci. Suppl. 40, p. S306 (1999). Presented at the 1999 annual meeting of the Association for Research in Vision and 13 Ophthalmology. 51. Magbalon, M.J. Johnson, M.A., Hemady, R.K., Rutzen, A.R.: Retinal pigment epithelial functional changes with plaquenil: How much is toxic? Invest. Ophthal. Vis Sci. Suppl. 40, p. S989 (1999). Presented at the 1999 annual meeting of the Association for Research in Vision and Ophthalmology. 52. Paul, S., Krauss, G., Johnson, M.A., Dollar, L., Miller, N.R.: Progression and recovery of visual function in patients treated with vigabatrin. Presented at the 23rd Meeting of the International Epilepsy Congress, 1999. 53. Krauss, G.L., Johnson, M.A., Miller, N.R., Paul, S.: Visual loss from vigabatrin: Effect of stopping the drug. Presented at the 1999 annual meeting of the American Epilepsy Society. 54. Fortune, B., Cioffi, G.A., Johnson, C.A., Bearse, M.A., Johnson, M.A.: Topographic assessment of function in glaucoma: Comparison of three different modes of multifocal ERG stimulation. Invest. Ophthal. Vis Sci. Suppl. 41, p. S326 (2000). Presented at the 2000 annual meeting of the Association for Research in Vision and Ophthalmology. 55. Johnson, M.A., Krauss, G.L., Miller, N.R., Medura, M., Paul, S.: Visual loss from vigabatrin: Effect of stopping the drug. Invest. Ophthal. Vis Sci. Suppl. 41, p. S357 (2000). Presented at the 2000 annual meeting of the Association for Research in Vision and Ophthalmology. 56. Lutty, G.A., McLeod, D.S., Otsuji, T., Flower, R.W., Bodkin, N., Steidl, S., Hansen, B.C., Johnson, M.A.: Diabetic angiopathic and functional changes in eyes of monkeys with spontaneous type 2 diabetes. Invest. Ophthal. Vis Sci. Suppl. 41, p. S405 (2000). Presented at the 2000 annual meeting of the Association for Research in Vision and Ophthalmology. 57. Singh, G.J., Hutcheson, K.A., Sutter, E.E., Johnson, M.A.: Retinal abnormalities identified by multifocal ERG in patients with amblyopia. Invest. Ophthal. Vis Sci. Suppl. 41, p. S534 (2000) Presented at the 2000 annual meeting of the Association for Research in Vision and Ophthalmology. 58. Johnson, M.A., Lutty, G.A., McLeod, D.S., Flower, R.W., Steidl, S. M., Bodkin, N., Hansen, B.C.: Retinopathy in monkeys with spontaneous type 2 diabetes. Presented at the 2000 annual meeting of the American Diabetes Association. 59. Bernstein, S.L., Yan, L., Nguyn, A., Flower, R., Kelman, S.E., Johnson, M.A.: A true model of anterior ischemic optic neuropathy. Invest. Ophthal. Vis Sci. Suppl. 42, p. S937 (2001). Presented at the 2001 annual meeting of the Association for Research in Vision and Ophthalmology. 60. Johnson, M.A., McLeod, D.S., Steidl, S. M., Flower, R.W., Bodkin, N., Hansen, B.C., Lutty, G.A.: Retinopathy and choroidopathy in monkeys with spontaneous type 2 diabetes. . Presented at the 2001 annual meeting of the European Association for the Study of Diabetes, Edinburgh, Scotland. In press, Diabetelogica. 61. Johnson, M.A., Lutty, G. A., McLeod, D. S., Kim, S. Y., Alexander, T., Shilling, R., McEvoy S., Harrell, M., Steidl, S. M., Hansen, B. C. Retinal Function and Pathology in the Spontaneously Diabetic Monkey Eye. Presented at the 2002 annual meeting of the Association for Research in Vision and Ophthalmology. 62. Johnson, M.A., Lutty, G. A., McLeod, D. S., Kim, S. Y., Shilling, R., McEvoy S., Harrell, M., Steidl, S. M., Bodkin, N., Hansen, B. C.: Retinopathy and Hypertension in Monkeys with Type II Diabetes. Diabetes 2002 Jun; 51 Suppl. 2. Presented at the 2002 annual meeting of the American Diabetes Association, San Francisco, CA. 63 . Johnson MA, Lutty, GA, McLeod DS, Kim SY, Steidl SM, Hansen BC: Risk factors for retinopathy in spontaneously-diabetic monkeys. Presented at the 2003 Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl., May 4-9, 2003. 64. Johnson, M.A., Lutty, G.A., McLeod, D.S., Otsuji, T., Shilling, R., McEvoy, S., Alexander, T., Steidl, S.M., Hansen, B.A.: Choroidopathy in the Spontaneously Diabetic Monkey. Presented to the NIH symposium on Animal Models of Complications of Diabetes, October, 2003, Rockville, MD. 65. Johnson MA: Risk factors for retinopathy in the spontaneously diabetic monkey. Endocrinology Grand Rounds, March 23, 2004. 66. Lutty GA, Kim SY, McLeod DS, Alexander T, Hansen BC, Johnson, MA: Increased numbers of neutrophils in retina are associated with presence of retinopathy and systemic levels of lipids. Presented at the 2004 Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl., April 25-29, 2004. 67. Kim SY, Johnson MA, McLeod DS, Alexander T, Hansen BC, Lutty GA: Morphpmetric analysis of retinal ganglion cells in spontaneously diabetic monkeys. Presented at the 2004 Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl., April 25-29, 2004. 14 68. Johnson MA, Lutty GA, McLeod DS, Otsuiji T, Shilling R, McEvoy S, Alexander T, Steidl SM, Hansen BC: Choroidopathy in the Spontaneously-Diabetic Monkey. Presented at the 2004 Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl., April 25-29, 2004. 69. Johnson MA, Newman SA, Calvert PC: The role of the multifocal ERG in diagnosing patients with AZOOR. Presented at the 2004 annual meeting of the International Society for Clinical Electrophysiology of Vision, Dorado Beach, Puerto Rico, November 14-18, 2004. 70. Johnson MA, Wilson L, Wang K, Morris JG: Visual contrast sensitivity in Chesapeake Bay watermen. . Presented at the 2005 Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl., May 1-5, 2005. 71. Kim SY, Hasegawa T, Merges C, Grebe R, McLeod DS, Johnson MA, Hansen BC, Lutty GA: Expression of Intracellular Adhesion Molecule-1 (ICAM-1) and Tumor Necrosis Factor-Alpha (TNF-a) in Eyes of Spontaneous Type 2 Diabetic Monkeys. Presented at the 2005 Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl., May 1-5, 2005. 72. Johnson MA, Lutty GA, McLeod DS, Kim SY, Alexander T, Schilling R, McEvoy S, Hansen BC: Retinal Function and Structure in the Spontaneously Diabetic Monkey. Presented at the 2005 Annual Meeting of the International Society for Clinical Electrophysiology of Vision, Glasgow, Scotland, August 23 – 27, 2005. 73. Chen CS, Johnson MA, Slater BJ, Miller NR, Bernstein SL: Clinical, functional and cellular responses in a novel primate model of non-arteritic anterior ischemic optic neuropathy (pNAION). Presented at the 2007 NANOS meeting, Snowbird, UT, Feb 2007. 74. Bernstein, SL Chen, C, Miller, NR, Slater, BJ, Johnson, MA: A Primate Model of Nonarteritic Anterior Ischemic Optic Neuropathy (pNAION). Presented at the 2007 Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl., May 2007. 75. Chen, CS, Johnson, MA, Slater, BJ, Miller, NR, Bernstein, SL: A novel primate model of nonarteritic anterior ischemic optic neuropathy (pNAION). Presented at the May, 2007 meeting of the European Neuro-ophthalmology Society (EUNOS), Istambul, Turkey. 76. Johnson, MA, Lyons, JS, Severns, ML: Autoimmune Retinopathy in Patients Taking Plaquenil? ARVO 2008. 77. Touitou V, Johnson MA, Miller NR, Guo, Y., Bernstein D, Bernstein SL: Sustained neuroprotection after a single intravitreal injection of PGJ2 in a rodent model of NAION. Presented by V. Touitou at the 2010 meeting of NANOS (North American Neuro-ophthalmologic Society). 78. Johnson, MA: Monitoring plaquenil toxicity: Is early detection enough? Presented at the May, 2010 ARVO meeting. 79. Johnson MA, Touitou V, Miller NR, Nicholson JD, Bernstein SL: Successful treatment of nonarteritic anterior ischemic optic neuropathy (NAION) in rodent and primate animal models. Presented to the 2010 Annual Meeting of the International Society for the Clinical Electrophysiology of Vision, Nov. 10, 2010, Fremantle, AUS. 80. Bernstein SL, Johnson MA, Miller NR: PGJ2 is neuroprotective in primate nonarteritic anterior ischemic optic neuropathy. Presented at the May, 2011 ARVO meeting. 81. Bhutto IA, Yates JR, Kim SY, McLeod DS, Johnson MA, Merges C, Hansen BC, Lutty GA: Expression of Inflammatory Mediators in Eyes of Spontaneously Type-2 Diabetic Monkeys. Presented to the 2013 ARVO annual meeting. 82. Johnson MA, Miller NR, Bernstein SL: Peripapillary Edema Is Associated with Nerve Fiber Layer Atrophy in a Primate Model of Nonarteritic Anterior Ischemic Optic Neuropathy. Presented to the 2013 ARVO annual meeting. 83. Johnson MA, Gelderblom H, Ruther K, Priller J, Bernstein SL: Evidence that Huntington’s Disease Affects Retinal Structure and Function. Presented to the 2014 annual meeting of the Association of Research in Vision & Ophthalmology in Orlando, FL, May 2014. 84. Johnson MA, Miller NR, Bernstein SL: "Lucentis is Not Neuroprotective in a Primate Model of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)". Presented to the 2015 ARVO annual meeting. 85. Johnson MA, Miller NR, Bernstein SL: Evidence consistent with compartment syndrome in a primate model of NAION. Presented to the 2015 annual meeting of ISCEV in Ljubljana, Slovenia.

15 86. Johnson MA, Guo Y, Mehrabian Z, Mishra MK, Rangaramanujan K, Miller NR, Bernstein SL: Nanoparticle-mediated neuroprotection in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION). Presented to the 2016 ARVO annual meeting.

Letters to the Editor: 1. Johnson, MA, Cadavid, D: Simvastatin in Acute Optic Neuritis. Multiple Sclerosis J., 18(11):1657 (2012) .

Editorials: 1. Johnson, M.A., Applegate, R.A.: Noninvasive assessment of the visual system - an introduction. Applied Optics 26 (editorial), pg. 1377 (1987). 2. Applegate, R.A., Johnson, M.A., Burns, S.A.: Noninvasive assessment of the visual system. Goals and history. Applied Optics 27 (editorial), pg. 1013 (1988). 3. Burns, S.A., Applegate, R.A., Johnson, M.A.: Noninvasive assessment of the visual system. Introduction. Applied Optics 28 (editorial), pp. 1058 - 1060 (1989). 4. Johnson, M.A., Burns, S.A., Applegate, R.A.: Noninvasive assessment of the visual system - introduction by the feature editors. Applied Optics (Optical Technology) 30, (editorial) 2071-2072 (1991). 5. Applegate, R.A., Johnson, M.A., Burns, S.A.: Is biomedical research a national priority? Applied Optics 30 (feature editorial), 2069 - 2070 (1991).

Book Reviews: Johnson, M.A. Am. J. Ophthal. 132, p. 142 (2001). Review of Fishman, G.A., Birch, D.G., Holder, G.E., Brigell, M.G.: “Electrophysiologic Testing in Disorders of the Retina, Optic Nerve and Visual Pathways”. 2nd edition. The Foundation of the American Academy of Ophthalmology, 2001.

Miscellaneous Publications: 1. Report on "Noninvasive Assessment of Visual Function" OSA Topical Meeting, Optics News 11, no. 2, 36 (1985). 2. Report on the 1985 Noninvasive Assessment of Visual Function OSA Topical Meeting, Optics News 11, no. 12, 18 (1985). 3. Report on the 1986 Noninvasive Assessment of Visual Function OSA Topical Meeting, Optics News 12, no. 2, 4 (1986). 4. Johnson, M.A.: Predicting neovascularization with the electroretinogram in central retinal vein occlusion. The Eye Report, the University of Texas Health Science Center at San Antonio (1989). 5. Applegate, R.A., Johnson, M.A., Burns, S.A.: Is biomedical research a national priority? The Eye Report, the University of Texas Health Science Center at San Antonio, 9:1 (1991). 6. Johnson, M.A.: The changing tide of U.S. science policy. Optics and Photonics News 5, 50-51 (1994).

Major Invited Lectures 1. Johnson, M.A.: Color vision in the peripheral retina. Presented at the December, 1982, annual meeting of the American Academy of Optometry. 2. Johnson, M.A.: Spatial properties of chromatic mechanisms in the peripheral retina. Presented to the NEI clinical research laboratory, March 11, 1983. 3. Johnson, M.A.: Critical flicker fusion in the periphery. Presented at the First Annual Symposium, "Functions of Non-Foveal Vision" of the Institute for Vision Research of the SUNY College of Optometry. October 20-21, 1984. 4. Johnson, M.A.: Relation of sensitivity loss to retinal pathology in age-related macular degeneration. Presented at the Wilmer Retinal Vascular Center's 15th Anniversary: Workshop on Choroidal Neovascularization. New Seabury, Cape Cod, MA, August 1-4, 1985.

16 5. Johnson, M.A.: The ERG in retinal ischemia. Presented at the NEI grand rounds, August 25, 1985. 6. Johnson, M.A.: Predicting the development of retinal and iris neovascularization with the electroretinogram. Presented at the Neurological Sciences Institute, Good Samaritan Hospital, Portland, Oregon. March 31, 1986. 7. Johnson, M.A.: Visual function changes and neovascularization in ischemic retinopathies. Presented at the Pittsburgh Eye and Ear Hospital, Pittsburgh, PA. October 9, 1986. 8. Johnson, M.A.: Carotid artery disease and central retinal vein occlusion. Presented to the Biometry division of the NEI, October, 1987. 9. Johnson, M.A.: The electroretinogram in central retinal vein occlusion. Presented to the Department of Ophthalmology and Visual Science, The University of Chicago, Chicago, IL. June 15, 1988. 10. Johnson, M.A.: Symposium participant in session "What, if anything is "normal" aging visual function? Presented on July 18, 1988, at the 35th anniversary symposium of the Lighthouse in New York. Symposium title: Age-Related Vision Loss: Development in Low Vision Practice and Research. 11. Johnson, M.A.: Predicting neovascularization with the electroretinogram in central retinal vein occlusion. Presented to the Department of Ophthalmology, The University of Texas Health Sciences Center at San Antonio, April 7, 1989. 12. Johnson, M.A.: Application of the Naka-Rushton equation to electroretinography. Presented in a symposium on "Noninvasive Assessment of the Visual System" at the fourth annual meeting of the American Academy of Clinical Neurophysiology, July 9, 1989, in Boston, MA. 13. Johnson, M.A.: Visual function as a prognostic indicator. Presented at the fifth annual Scheie Eye Institute Symposium on Low Vision, in Philadelphia, PA, Nov. 18, 1989. 14. Johnson, M.A.: Understanding Mechanisms of Visual Function Loss Using the ERG. Presented to the NYU Department of Psychology, October, 1990. 15. Johnson, M.A.: What is the role of the choroidal circulation in central retinal vein occlusion? Presented at the Eye Research Institute in Boston, MA, August, 1992. 16. Johnson, M.A.: The electroretinogram and hypoxia. Presented to the Naval Research Laboratory, Washington, D.C., on July 16, 1993. 17. Johnson, M.A.: When to order an ERG. Presented at the “Retina for the Comprehensive Ophthalmologist” course, S. Steidl, director; Sept 26, 1997. 18. Miller, N.R. and Johnson, M.A.: Vigabatrin toxicity in the retina. Presented to the Wilmer Institute Friday Afternoon Research Meeting, Jan. 15, 1999. 19. Johnson, M.A.: Laser Applications in Ophthalmology. Presented as part of the Lasers and Electro- optics Program (LEAP) of the annual Conference on Lasers and Electro-optics/Quantum Electronics and Laser Science Conference (CLEO/QELS) in Baltimore, MD, May 27, 1999 20. Johnson, M.A.: Researcher-clinician collaborations: The ten stupid things researchers do to make themselves miserable. Presented at the third meeting of the North American Perimetric Society at the Dominican College of San Rafael, San Rafael, CA on 9-11 July, 1999. 21. Johnson, M.A.: Chorioretinopathy in primates with spontaneous type II diabetes. Presented to the Schepens Eye Research Institute, Boston, MA, September 28, 2001. 22. Johnson, MA: “ The Electroretinogram in Retinal Ischemia” and “The Electroretinogram in AZOOR”. Presented at a seminar hosted by LKC Technologies, Inc., at the 2006 Annual Meeting of the American Academy of Ophthalmology in Las Vegas, NV. 23. Johnson, MA: “What we have learned from the monkey model of NAION”. Keynote speaker, 15th Chinese Congress on Visual Physiology, Shenzhen, China, June, 2016.